Age and the ability to meet basic needs were the only two factors that significantly correlated with adherence to antiretroviral treatment, according to a recent study conducted by a family medicine doctor working in Hinche, Haiti.

PIH clinicians assessed cancer care at HUM and published their findings in The Oncologist

In Chiapas, contact tracing is challenging—but not impossible. New research in The Lancet Global Health details PIH's COVID-19 response in rural Mexico.

Integrating care for HIV and non-communicable diseases such as hypertension, diabetes, and mental illness, all under one roof, is making treatment more accessible and effective in Neno District 

Dr. Carole Mitnick, co-principal investigator for the endTB project and a senior tuberculosis researcher with PIH, discusses her team's newest clinical trial--launched amidst the COVID-19 pandemic--and the promise it holds for marginalized communities.

Tatiana Therosme gathered herself for a moment before talking about a young woman, born with HIV, who battled severe depression for years because of stigmatization and mistreatment resulting from people’s perceptions of her diagnosis. The young woman's mental health care is a testament to a system that has grown to serve thousands.

PIH and Harvard Medical School have provided research mentoring and resources to more than 50 health workers in Rwanda over the past five years, working to overcome systemic barriers.

Researchers from Canada, Harvard and PIH are examining how the pandemic is affecting people's use of health services amid the global crisis, to provide vital data for national responses around the world.

PIH researchers, clinicians helped lead study that again showed new-generation TB drugs to be more effective, including for patients with additional diseases.